Cancer Genetics and Genomics for Personalized Medicine
179,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
90 °P sammeln
  • Gebundenes Buch

This book covers almost all fields of cancer genetics and genomics for personalized medicine. Surely, the one-fits-all approach does not work anymore for disease treatment. Targeted therapy or precision medicine or personalized medicine is becoming a standard for many disease treatments including cancer. However, how much do we know about the personalized medicine approach? This book will help undergraduate/graduate students, professional researchers, and clinicians to better understand the key concept of personalized medicine.

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book covers almost all fields of cancer genetics and genomics for personalized medicine. Surely, the one-fits-all approach does not work anymore for disease treatment. Targeted therapy or precision medicine or personalized medicine is becoming a standard for many disease treatments including cancer. However, how much do we know about the personalized medicine approach? This book will help undergraduate/graduate students, professional researchers, and clinicians to better understand the key concept of personalized medicine.
Autorenporträt
Il-Jin Kim is principal investigator and director of Applied Genomics in the UCSF Thoracic Oncology Program. His work focuses on the identification of novel therapeutic targets and diagnostic markers for various types of human cancers. Dr. Kim investigates human cancers using state-of-the-art technologies, including next-generation sequencing (NGS) and system genetic tools that he developed with his team. He has developed several innovative microarrays and pioneered new methods of high-throughput mutation screening, for which he holds numerous patents. He has published more than 70 papers, including in Science and Nature Communications. He has also received three awards from the American Association for Cancer Research for developing innovative genetic and diagnostic assays.